Camptosar Related Clinical Trials
Ph I SU011248 + Irinotecan in Treatment of Pts w MG [Active, not recruiting]
Ph. I Temo + O6-BG + Irinotecan in Treatment of Pts w Recurrent / Progressive Cerebral Anaplastic Gliomas [Active, not recruiting]
Ph. II Treatment of Adults w Primary Malignant Glioma w Irinotecan + Temo [Active, not recruiting]
CAmpto-CISplatine Plus Radiotherapy in Advanced Cervix Cancer : Search of Tolerated Maximum Dose of Campto [Completed]
Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric Cancer [Active, not recruiting]
Cetuximab Combined With Irinotecan in First-Line Therapy for Metastatic Colorectal Cancer (CRYSTAL) [Active, not recruiting]
Ph II Bev + Either Temo/Etoposide for GBM Pts Who Have Failed Bev + Irinotecan [Active, not recruiting]
Phase II Trial of Preoperative Combined Modality Therapy for Esophageal Carcinoma: Cisplatin-Irinotecan Followed by Radiation Therapy With Concurrent Cisplatin and Irinotecan. [Active, not recruiting]
Celecoxib, Irinotecan and Concurrent Radiotherapy in Preoperative Pancreatic Cancer [Active, not recruiting]
Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas [Active, not recruiting]
Trial of Irinotecan in Combination With Three Methods of Administration of Fluoropyrimidine.
Phase I / II Study of Irinotecan (CPT-11) Combined With l-Leucovorin (l-LV) and 5-FU in Patients With Advanced Colorectal Cancer [Completed]
Liposome Encapsulated SN38 (LE-SN38) in Patients With Advanced Cancer [Active, not recruiting]
Irinotecan, 5-Fluorouracil, and Leucovorin in Colorectal Carcinoma [Active, not recruiting]
Dose-Finding Study of E7070 in Combination With Irinotecan [Active, not recruiting]
A Study of Irinotecan, Cisplatin and Celebrex in Patients With Metastatic or Unresectable Esophageal Cancer [Terminated]
Bevacizumab and Cetuximab With or Without Irinotecan in Treating Patients With Irinotecan-Refractory Metastatic Colorectal Cancer [Completed]
A Phase I Study of Irinotecan (CPT-11) Administered as a Prolonged Infusion in Adult Patients With Solid Tumors [Completed]
Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer [Active, not recruiting]
Irinotecan Versus Only Best Supportive Care for Gastric Cancer [Completed]
Prevention of Diarrhea in Patients Taking IV Irinotecan for Relapsed or Difficult to Treat Pediatric Solid Tumors [Recruiting]
Phase I Irinotecan, 5-Fluorouracil and Leucovorin Combination [Active, not recruiting]
Cisplatin, CPT-11 and Celecoxib With Radiation Therapy and Surgery for Operable Esophageal Cancer [Active, not recruiting]
Phase I Study of Capecitabine in Combination With Cisplatin and Irinotecan [Active, not recruiting]
Irinotecan (Camptosar) in Patients With Advanced Sarcomas [Recruiting]
Three Combinations Of Docetaxel And Irinotecan For Recurrent Or Metastatic Non Small Cell Lung Cancer
Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma [Suspended]
High Dose CPT-11 in Recurrent Unresectable Malignant Glioma [Recruiting]
Study of Irinotecan in Children
Irinotecan in Treating Patients With Metastatic or Recurrent Breast Cancer [Completed]
CS-1008 Used With Irinotecan Versus Irinotecan Alone in Subjects With Metastatic Colorectal Carcinoma Who Failed First-line Treatment With Oxaliplatin [Recruiting]
A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas [Recruiting]
Irinotecan in Treating Patients With Newly Diagnosed or Relapsed Non- Hodgkin's Lymphoma or Leukemia [Active, not recruiting]
Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme [Recruiting]
Panitumumab DDI Irinotecan [Recruiting]
Combining Temozolomide, Oncovin, Irinotecan and Oral Antibiotic in Children and Adolescents With Recurrent Malignancy [No longer recruiting]
Avastin in Combo w XRT & Temozolomide , Followed by Avastin, Temozolomide & Irinotecan for GBM & Gliosarcomas [Recruiting]
Irinotecan and Cisplatin in Treating Patients With Locally Advanced or Metastatic Penile Cancer [Active, not recruiting]
Irinotecan Plus Radiation Therapy Followed By Chemotherapy in Treating Patients With Glioblastoma Multiforme [Active, not recruiting]
Thalidomide and Temozolomide or Camptothecin-11 (CPT-11) in Patients With Gliomas [Recruiting]
Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Intravenous Oxaliplatin Plus Irinotecan in Patients With Unresectable Hepatic Metastases From Colorectal Cancer [Recruiting]
Phase II Study of Oral S-1 Plus Irinotecan (IRIS) in Patients With Advanced Colorectal Cancer [Active, not recruiting]
CPT-11/Cisplatin and Celecoxib With Radiation Therapy for Patients With Unresectable Non-Small Cell Lung Cancer (NSCLC) [Recruiting]
Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancer [Recruiting]
A Phase II Study of Bevacizumab, Irinotecan and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer [Recruiting]
Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal Cancers [Recruiting]
Pilot Study Combining Temozolomide, Oncovin, Camptosar and Oral Antibiotic in Children and Adolescents With Recurrent Malignancy [Suspended]
Avastin/Temozolomide/Irinotecan for Unresectable/Multifocal Glioblastoma Multiforme Multiforme [Not yet recruiting]
SU011248 in Combination With Irinotecan and Cetuximab as a Second Line Regimen for Stage IV Colorectal Cancer [Active, not recruiting]
For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With Chemotherapy [Terminated]
Feasibility Study of CDDP + CPT-11 + PSK for Extensive-Stage Disease (ED) Small Cell Lung Cancer [Recruiting]
Taxotere, Cisplatin, and CPT-11 in Advanced Solid Tumor Malignancies [Active, not recruiting]
ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors [Recruiting]
Safety Study of ON 01910.Na in Combination With Irinotecan or Oxaliplatin [Recruiting]
Randomized Phase III Study of Folfiri+Avastin Versus Xeliri+Avastin as 1st Line Treatment of CRC [Recruiting]
Irinotecan in Treating Patients With Newly Diagnosed Ewing's Sarcoma [Recruiting]
Irinotecan/Cetuximab Followed by XELOX/Cetuximab vs the Reverse Sequence in Metastatic CRC [Recruiting]
Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma [Completed]
Irinotecan and Flavopiridol in Treating Patients With Advanced Liver Cancer [Completed]
Thalidomide and Irinotecan in Treating Patients With Glioblastoma Multiforme Who Have Undergone Radiation Therapy [No longer recruiting]
Irinotecan and Cyclosporine in Treating Patients With Metastatic, Advanced or Locally Recurrent Colorectal Cancer [No longer recruiting]
A Phase I Study of S-1 Plus Irinotecan and Oxaliplatin in Advanced Gastrointestinal Malignancy [Active, not recruiting]
Irinotecan and Carboplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer [Not yet recruiting]
Irinotecan or Fluorouracil Plus Leucovorin in Treating Patients With Previously Treated Metastatic Colorectal Cancer [No longer recruiting]
Gemcitabine and Irinotecan in Treating Patients With Locally Advanced or Metastatic Bladder Cancer [Recruiting]
Gemcitabine and Irinotecan in Treating Patients With Locally Advanced Unresectable or Metastatic Kidney Cancer [Recruiting]
Irinotecan and Docetaxel With or Without Cetuximab in Treating Patients With Metastatic Pancreatic Cancer [No longer recruiting]
Genotype-Directed Dose-Escalation Study of Irinotecan in Patients With Advanced Solid Tumors [Recruiting]
Irinotecan With or Without Panitumumab or Cyclosporine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Fluorouracil [Recruiting]
Chemoembolization, Irinotecan Bead, Second Line Chemotherapy Treatment of Unresectable Metastatic Colorectal Cancer [Recruiting]
Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma [Recruiting]
Safety of ON 01910.Na and Irinotecan or ON 01910.Na and Oxaliplatin in Patients With Hepatoma [Recruiting]
Clinical and Pharmacokinetic Trial of Intra-Abdominal Irinotecan [Recruiting]
Bevacizumab Plus Irinotecan Plus Carboplatin for Recurrent Malignant Glioma (MG) [Not yet recruiting]
Oxaliplatin/CPT-11 for Extensive Stage Small Cell Lung Cancer [Terminated]
Safety and Efficacy Study of Panitumumab+Irinotecan in Patients Wild-Type (WT) KRAS Metastatic Colorectal Cancer Refractory to Irinotecan Based Chemotherapy (SPECTRA) [Not yet recruiting]
Study of MK0646 in Combination With Cetuximab and Irinotecan in Metastatic Colorectal Cancer [Recruiting]
Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer [No longer recruiting]
Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus or Stomach [No longer recruiting]
Study Of Irinotecan Hydrochloride (Campto(R)) And Cisplatin Versus Etoposide And Cisplatin In Small Cell Lung Cancer [Recruiting]
Gefitinib, Cisplatin, Irinotecan, and Radiation Therapy Before Surgery in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery [Recruiting]
Study With Irinotecan in Patients With Advanced Solid Tumors Metastatic to the Liver [Recruiting]
Pre-Operative Chemo (CPT11, Cisplatin), Radiotherapy, Plus Surgery for Resectable Esophageal Cancer [No longer recruiting]
Study of Irinotecan and Bortezomib in Children With Recurrent/Refractory Neuroblastoma [Recruiting]
A Study of Gliadel Followed by Avastin + Irinotecan for Glioblastoma Multiforme (GBM) [Recruiting]
Phase I/II Study of Irinotecan and Temsirolimus in Patients With Refractory Sarcomas [Recruiting]
A Clinical Study of PHY906 as a Modulator of CPT-11 in Patients With Metastatic Colorectal Cancer [Recruiting]
Irinotecan in Treating Young Patients With Refractory or Recurrent Hepatoblastoma [Recruiting]
Yttrium Microspheres With Cetuximab Plus Irinotecan for Patients With Advanced Colorectal Cancer Mets to Liver [Not yet recruiting]
Phase I Single Ascending Dose/Multiple Ascending Dose in Patients Treated With AZD7762 and Irinotecan [Recruiting]
Irinotecan, Carboplatin, and Sunitinib in First Line Extensive-Stage Small Cell Lung Cancer [Recruiting]
A Study of EZN-2208 Administered With or Without Cetuximab in Patients With Metastatic Colorectal Carcinoma [Recruiting]
Phase II Study of Avastin + Erbitux + Irinotecan as 2nd Line Treatment of Colorectal Cancer [Recruiting]
Capecitabine + Irinotecan Followed by Combined Modality Capecitabine and Radiation in Locally Advanced Rectal Cancer [Recruiting]
A Study of 1018 ISS Administered With Irinotecan and Cetuximab to Treat Patients With Previously Treated Metastatic Colorectal Cancer [Recruiting]
Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and Cisplatin [Recruiting]
Irinotecan in Patients With Advanced Metastatic Breast Cancer Who Have Experienced Failure of an Anthracycline, a Taxane, and Capecitabine [Completed]
A Phase II Trial With Cetuximab, Bevacizumab and Irinotecan for Patients With Malignant Glioblastomas [Recruiting]
Irinotecan and Cisplatin for High Grade Neuroendocrine Carcinoma of the Gastrointestinal Tract [Recruiting]
Bortezomib With or Without Irinotecan in Treating Patients With Recurrent or Metastatic Head and Neck Cancer [Recruiting]
Irinotecan With or Without Capecitabine as Second-Line Therapy in Treating Older Patients With Progressive, Metastatic Colorectal Cancer That Cannot Be Removed By Surgery [Recruiting]
|
